Posted by Michael Wonder on 31 May 2021
Eton Pharmaceuticals receives complete response letter from U.S. FDA for dehydrated alcohol injection
28 May 2021 - Eton Pharmaceuticals today announced that the company has received a complete response letter from the U.S. FDA in response to the submission of its new drug application for dehydrated alcohol injection for the treatment of methanol poisoning.
The letter indicated that the FDA has completed its review of the application and has determined that the application cannot be approved in its present form.
